Scientific Advisor at Imvax
Tyler Curiel is a physician-scientist, Professor of Medicine and Microbiology, Immunology and Molecular Genetics at University of Texas Health San Antonio and holds the Daisy M. Skinner President’s Chair in Cancer Immunology Research. He received his BS summa cum laude from the University of Georgia, his MPH from Harvard and his MD from Duke. He completed internal medicine training at Yale, Infectious Disease training at Harvard/Massachusetts General Hospital and Medical Oncology training at the University of Colorado. He has significant NIH and other grant support and has served in many national and international leadership roles, including currently as a consulting editor for the Journal of Clinical Investigation. His lab investigates the immunopathogenic basis of human disease with an emphasis on novel strategies for cancer immunotherapy, concepts of which have been put into human clinical trials. Current work focuses on novel aspects of immune checkpoint blockade, pathogenic effects of regulatory T cells and on engineered cytokines.